NO812937L - Fremgangsmaate ved fremstilling av terapeutisk virksomt n-(1-allyl-2-pyrrolidinyl-methyl)-2-methoxy-4-amino-5-methylsulfamoyl-benzamid - Google Patents

Fremgangsmaate ved fremstilling av terapeutisk virksomt n-(1-allyl-2-pyrrolidinyl-methyl)-2-methoxy-4-amino-5-methylsulfamoyl-benzamid

Info

Publication number
NO812937L
NO812937L NO812937A NO812937A NO812937L NO 812937 L NO812937 L NO 812937L NO 812937 A NO812937 A NO 812937A NO 812937 A NO812937 A NO 812937A NO 812937 L NO812937 L NO 812937L
Authority
NO
Norway
Prior art keywords
methylsulphamoyl
benzamide
pyrrolidinyl
allyl
methoxy
Prior art date
Application number
NO812937A
Other languages
English (en)
Other versions
NO155097B (no
NO155097C (no
Inventor
Jacques Perrot
Michel Thominet
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ile De France filed Critical Ile De France
Publication of NO812937L publication Critical patent/NO812937L/no
Publication of NO155097B publication Critical patent/NO155097B/no
Publication of NO155097C publication Critical patent/NO155097C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Hydrogenated Pyridines (AREA)
NO812937A 1980-08-28 1981-08-28 Analogifremgangsmaate ved fremstilling av terapeutisk aktivt n-(1'-allyl-2'-pyrrolidinylmethyl)-2-methoxy-4-amino-5-methylsulfamoylbenzamid. NO155097C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8018635A FR2489327B1 (fr) 1980-08-28 1980-08-28 N (1 allyl 2 pyrrolidinyl methyl) 2 methoxy 4 amino 5 methylsulfa moyl benzamide, son procede de preparation et son application comme medicament

Publications (3)

Publication Number Publication Date
NO812937L true NO812937L (no) 1982-03-01
NO155097B NO155097B (no) 1986-11-03
NO155097C NO155097C (no) 1987-02-11

Family

ID=9245444

Family Applications (1)

Application Number Title Priority Date Filing Date
NO812937A NO155097C (no) 1980-08-28 1981-08-28 Analogifremgangsmaate ved fremstilling av terapeutisk aktivt n-(1'-allyl-2'-pyrrolidinylmethyl)-2-methoxy-4-amino-5-methylsulfamoylbenzamid.

Country Status (41)

Country Link
US (2) US4405636A (no)
EP (1) EP0047207B1 (no)
JP (1) JPS5775969A (no)
KR (1) KR840002063B1 (no)
AR (1) AR226737A1 (no)
AT (1) ATE11911T1 (no)
AU (1) AU549396B2 (no)
BE (1) BE890085A (no)
BG (1) BG36931A3 (no)
CA (1) CA1168250A (no)
CH (1) CH648299A5 (no)
CS (1) CS223895B2 (no)
DD (1) DD202011A5 (no)
DE (2) DE3169052D1 (no)
DK (1) DK157845C (no)
EG (1) EG15376A (no)
ES (1) ES503805A0 (no)
FI (1) FI73207C (no)
FR (1) FR2489327B1 (no)
GB (1) GB2083033B (no)
GR (1) GR74560B (no)
HK (1) HK55989A (no)
HU (1) HU183555B (no)
IE (1) IE51357B1 (no)
IL (1) IL63217A (no)
IN (1) IN155495B (no)
IS (1) IS1213B6 (no)
IT (1) IT1171490B (no)
JO (1) JO1120B1 (no)
LU (1) LU83583A1 (no)
MA (1) MA19218A1 (no)
MX (1) MX6707E (no)
NO (1) NO155097C (no)
OA (1) OA06877A (no)
PH (1) PH19211A (no)
PL (1) PL135397B1 (no)
PT (1) PT73509B (no)
SU (1) SU1148559A3 (no)
YU (1) YU42581B (no)
ZA (1) ZA814575B (no)
ZW (1) ZW17581A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8317597D0 (en) * 1983-06-29 1983-08-03 Beecham Group Plc Pharmaceutical compounds
FR2550447B1 (fr) * 1983-08-10 1986-01-17 Ile De France Application du n-(ally-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide comme antiagregant plaquettaire
FR2584605B1 (fr) * 1985-07-15 1988-06-17 Ile De France Application du n-(1-allyl-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide dans le traitement de la maladie de parkinson
US7544676B2 (en) * 2005-11-10 2009-06-09 Adolor Corporation Sulfamoyl benzamides and methods of their use
CN101628886B (zh) * 2009-08-25 2012-12-12 北京紫萌同达科技有限公司 一种2-甲氧基-4-氨基-5-乙砜基苯甲酸的合成方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1525M (fr) * 1961-07-25 1962-11-16 Ile De France Médicaments antiémétiques nouveaux.
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
FR5916M (no) * 1966-01-21 1968-05-06
US3766178A (en) * 1967-04-03 1973-10-16 Ile De France Substituted 2-arylalkyloxy benzamides
GB1364231A (en) 1968-12-23 1974-08-21 Robins Co Inc A H N-/1-substituted-3-pyrrolidinyl/benzamides and thiobenzamides
US3862139A (en) * 1972-06-23 1975-01-21 Delmar Chem Heterocyclic benzamide compounds
FR2244760B1 (no) * 1973-09-25 1980-06-27 Ile De France
CH605793A5 (no) * 1974-03-05 1978-10-13 Ile De France
FR2294698A1 (fr) * 1974-12-18 1976-07-16 Synthelabo Nouveaux derives des methoxy-2 benzamides substitues, leurs sels, leur preparation et les medicaments qui en renferment
US4197243A (en) * 1975-04-02 1980-04-08 Yamanouchi Pharmaceutical Co., Ltd. N-1-Benzyl-3-pyrrolidinyl-4-dimethylamino benzamide derivatives
US4186135A (en) * 1976-08-04 1980-01-29 Societe D'etudes Scientifiques Et Industrielles De L'ile-De-France Substituted 2,3-alkylene bis (oxy) benzamides and derivatives and method of preparation
FR2438650A1 (fr) * 1978-10-11 1980-05-09 Ile De France N-(1-methyl 2-pyrrolidinyl methyl) 2,3-dimethoxy 5-methylsulfamoyl benzamide et ses derives, leurs methodes de preparation et leur application dans le traitement des troubles du bas appareil urinaire
US4210660A (en) * 1978-12-20 1980-07-01 Yamanouchi Pharmaceutical Co., Ltd. Benzamide derivatives
JPS55130957A (en) * 1979-03-30 1980-10-11 Kyowa Hakko Kogyo Co Ltd Production of benzamide derivative

Also Published As

Publication number Publication date
AU7464281A (en) 1982-03-04
DE3169052D1 (en) 1985-03-28
GB2083033A (en) 1982-03-17
PH19211A (en) 1986-02-04
YU201081A (en) 1983-10-31
NO155097B (no) 1986-11-03
KR840002063B1 (ko) 1984-11-09
IS2654A7 (is) 1981-09-11
ZW17581A1 (en) 1981-10-21
LU83583A1 (fr) 1981-12-01
AR226737A1 (es) 1982-08-13
HU183555B (en) 1984-05-28
IL63217A (en) 1985-03-31
SU1148559A3 (ru) 1985-03-30
BE890085A (fr) 1982-02-26
PL135397B1 (en) 1985-10-31
JPH0233027B2 (no) 1990-07-25
FR2489327A1 (fr) 1982-03-05
MA19218A1 (fr) 1982-04-01
GB2083033B (en) 1984-02-01
FI73207B (fi) 1987-05-29
JPS5775969A (en) 1982-05-12
GR74560B (no) 1984-06-29
EG15376A (en) 1986-12-30
EP0047207B1 (fr) 1985-02-20
YU42581B (en) 1988-10-31
IN155495B (no) 1985-02-09
IL63217A0 (en) 1981-10-30
FI73207C (fi) 1987-09-10
HK55989A (en) 1989-07-21
CA1168250A (fr) 1984-05-29
DK383081A (da) 1982-03-01
PL232686A1 (no) 1982-03-01
NO155097C (no) 1987-02-11
PT73509B (fr) 1982-10-28
BG36931A3 (en) 1985-02-15
EP0047207A1 (fr) 1982-03-10
IE51357B1 (en) 1986-12-10
US4405636A (en) 1983-09-20
IS1213B6 (is) 1986-04-02
ZA814575B (en) 1982-07-28
DE3133768A1 (de) 1982-06-16
DK157845C (da) 1990-07-23
CH648299A5 (fr) 1985-03-15
IT8149179A0 (it) 1981-08-26
IT1171490B (it) 1987-06-10
FR2489327B1 (fr) 1984-05-18
ATE11911T1 (de) 1985-03-15
KR830006201A (ko) 1983-09-20
DD202011A5 (de) 1983-08-24
FI812506L (fi) 1982-03-01
PT73509A (fr) 1981-09-01
DK157845B (da) 1990-02-26
IE811449L (en) 1982-02-28
ES8301466A1 (es) 1982-12-01
MX6707E (es) 1985-10-23
ES503805A0 (es) 1982-12-01
US4550179A (en) 1985-10-29
AU549396B2 (en) 1986-01-23
JO1120B1 (en) 1982-07-10
CS223895B2 (en) 1983-11-25
OA06877A (fr) 1983-04-30

Similar Documents

Publication Publication Date Title
NO801155L (no) Fremgangsmaate ved fremstilling av acyl-carnitinamider
NO832773L (no) Fremgangsmaate ved fremstilling av et terapeutisk aktivt cefuroxim-derivat.
NO802913L (no) Fremgangsmaate ved fremstilling av cephalosporinforbindelse
NO153135C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme n-(fenoksyalkyl)-imidazolderivater.
NO810014L (no) Fremgangsmaate ved fremstilling av kikhostetoksoid
NO810675L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO151702C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte acetofenoner
NO814065L (no) Fremgansmaate for fremstilling av imidazolylfenylamidiner
NO814055L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive thienopyridinonderivater
NO844243L (no) Fremgangsmaate for fremstilling av terapeutisk virksomme forbindelser
NO831588L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive 4-aryl-4-piperidincarbinoler
NO157976C (no) Analogifremgangsm te ved fremstilling av terapeutisk aktive 3-fenoxy-1-azetidincarboxamider.
NO820281L (no) Fremgangsmaate ved fremstilling av n-(halogenmethyl)-acylamider
NO843377L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater
ES487148A0 (es) Procedimiento de preparacion de nuevas trifluoroetilaminas n-sustituidas
NO151196C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme fluorerte alkenylendiaminderivater
NO813814L (no) Fremgangsmaate for fremstilling av monoalkyletere av hydrokinonforbindelser
NO152128C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-amino-3-benzoylfenylacetamider
NO813263L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolon-derivater
NO812937L (no) Fremgangsmaate ved fremstilling av terapeutisk virksomt n-(1-allyl-2-pyrrolidinyl-methyl)-2-methoxy-4-amino-5-methylsulfamoyl-benzamid
NO812467L (no) Fremgangsmaate ved fremstilling av as-triazinderivater
NO831995L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-(2-metoksyetyl)-noroksymorfon
NO834424L (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme fentiazinforbindelser
NO814074L (no) Fremgangsmaate ved fremstilling av n-(halogenmethyl)-acylamider
NO153258C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenyl-kinolizidiner